Tasbeeh Ahmed: Exploring Anticoagulation in Antiphospholipid Syndrome
Tasbeeh Ahmed, Medical Doctor, shared a post on LinkedIn:
“A clot may be the event. APS may be the reason.
Despite the widespread adoption of DOACs, Antiphospholipid Syndrome (APS) remains one of the most important exceptions in modern anticoagulation.
For many patients with thrombotic APS, the choice of anticoagulant is not just a prescription – it can determine the risk of recurrent DVT, stroke, limb ischemia, or pregnancy complications.
- When is Warfarin still the gold standard?
- Why are DOACs discouraged in triple-positive APS?
- What should we do when thrombosis recurs despite therapeutic INR?
- How does management change during pregnancy?
I created this infographic to provide a concise, evidence-based overview of the latest APS anticoagulation recommendations and help clinicians navigate these critical decisions with confidence.
Because in APS, choosing the right anticoagulant can be the difference between preventing the next thrombosis – or missing the opportunity.
What has been your experience managing APS patients in clinical practice?”

Stay updated with Hemostasis Today.
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026
-
Sep 25, 2026, 05:33Urge Congress to support the Sickle Cell Disease Comprehensive Care Act – ASH
-
Sep 25, 2026, 05:24Isabelle Mahé: Reduced-Dose Apixaban in Extended CAT Treatment
-
Sep 25, 2026, 05:15Maria Cherska: High Cholesterol Isn’t Always Diet or Lifestyle – Sometimes It’s Genetic